COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 48: Articles 471-480  | Next

Completeness and timeliness of a contact tracing intervention during the COVID-19 pandemic: an outcome evaluation of the California Contact Tracing Support Initiative
Park, S., Grantz, K. H., Lee, K. H., Rosser, E., Aldos, L., Dutta, R., Peeples, L.-M., Gurley, E. S., Marx, M., Lee, E. C.
10.64898/2026.02.05.26345670 — Posted: 2026-02-06
Predictive Modeling of COVID-19 Variant Peak Prevalence and Duration Using GISAID Data Across 15 Countries
Zhang, Y., Rob, P., Chen, K., Overton, C. E., Jung, J., Jo, Y.
10.64898/2026.02.04.26345559 — Posted: 2026-02-05
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines
Kim, B., Roenicke, R., Roeder, P. M., Steinberg, I., Patamawenu, A., Harrison, M., Veer, F. v., Koory, E., Xie, J., Shofner, T., Matsuda, K., Wettstein, E., Ober, E., Cooney, C., Kim, T., Webber, J. D., Meeks, T., Burdette, T., Clark, S. G., Vostal, A. C., Hostal, A., Cohen, J. I., Gagne, M., Ziff, Z., Richard, K., Burnett, M. R., Maule, E., Callier, V., Liang, J., Kovacikova, G., Souter, S. C., Weiner, J. A., Douek, D., Ackerman, M. E., Wright, P. F., Johnson, R. F., Connors, M.
10.64898/2026.02.04.703921 — Posted: 2026-02-05
ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies
Song, Y., Mehl, F., No, T., Livingston, L., Quintero Barbosa, J. S., Hayashi, J., Serrero, G., Bortz, P. S., Wilson, J., Crowe, J. E., Ho, D. D., Yin, M. T., Tan, J., Zeichner, S. L.
10.64898/2026.02.02.703244 — Posted: 2026-02-05
Assessing COVID-19 Risk Factors in Toronto Using a Localized Spatio-Temporal Conditional Autoregressive Model
Amoako, A. A., Ge, E., Tuite, A., Carabali, M., Fisman, D.
10.64898/2026.02.03.26345488 — Posted: 2026-02-04
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study
Kung, E., Deo, R., Choudhary, M. C., Chew, K. W., Evering, T. H., Ignacio, R. B., Ignacio, R. B., Jagannathan, P., Flynn, J. P., Regan, J., Moser, C., Giganti, M. J., Hughes, M. D., Ritz, J., Javan, A. C., Greninger, A. L., Singh, U., Fischer, W., Daar, E. S., Wohl, D. A., Eron, J. J., Currier, J. S., Coombs, R. W., Smith, D. M., Li, J. Z.
10.64898/2026.01.31.26345293 — Posted: 2026-02-03
Functional and Structural Basis of Omicron BA.3.2.1 Spike
Wang, Y., Hu, Y., Chen, Z., Zou, J., Zhang, K., Ren, P., Shi, P.-Y., Liang, B., Xie, X.
10.64898/2026.02.02.702852 — Posted: 2026-02-03
Multiorgan Outcomes Following COVID-19 Vaccine vs Infection: 30M Analysis
Toraih, E. A., Bruce, D., Hussein, M. H., Aiash, H., Thomas, S. J.
10.64898/2026.01.30.25343064 — Posted: 2026-02-03
A Cross-Sectional Study of COVID-19 Vaccine Hesitancy and Behaviours among People Living with HIV in British Columbia
Ejiegbu, A. E., Shariati, B., Little, J., Brondani, M.
10.64898/2026.01.31.26345295 — Posted: 2026-02-03
SEVA: An externally driven framework for reproducing COVID-19 mortality waves without transmission feedback
Varming, K.
10.64898/2026.01.30.26345245 — Posted: 2026-02-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).